| JYZB1100020 | 注射用帕瑞昔布钠 | parecoxib sodium | Lyophilized | Chemical Drugs | Supplementary Application | 2011-10-18 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | In Review | 2011-10-12 | view |
| JYZB1100019 | 注射用帕瑞昔布钠 | parecoxib sodium | Lyophilized | Chemical Drugs | Supplementary Application | 2011-10-18 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | In Review | 2011-10-12 | view |
| JYHZ2100653 | 注射用帕瑞昔布钠 | parecoxib sodium | Lyophilized | Chemical Drugs | License Renew | 2021-10-14 | | | | | view |
| JYHZ2100652 | 注射用帕瑞昔布钠 | parecoxib sodium | Lyophilized | Chemical Drugs | License Renew | 2021-10-14 | | | | | view |
| JYHZ1600342 | 注射用帕瑞昔布钠 | parecoxib sodium | Lyophilized | Chemical Drugs | License Renew | 2017-06-26 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2018-01-24 | view |
| JYHZ1600341 | 注射用帕瑞昔布钠 | parecoxib sodium | Lyophilized | Chemical Drugs | License Renew | 2017-06-26 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2018-01-24 | view |
| JYHF1800023 | 注射用帕瑞昔布钠 | parecoxib sodium | Lyophilized | Chemical Drugs | Supplementary Application | 2018-02-09 | 辉瑞制药有限公司 | Pfizer Pharmaceuticals Ltd | Certificate Issued | 2018-03-13 | view |
| JYHB2400224 | 注射用帕瑞昔布钠 | parecoxib sodium | Lyophilized | Chemical Drugs | Supplementary Application | 2024-05-21 | | | | | view |
| JYHB2400110 | 注射用帕瑞昔布钠 | parecoxib sodium | Lyophilized | Chemical Drugs | Supplementary Application | 2024-02-29 | | | | | view |
| JYHB2100194 | 注射用帕瑞昔布钠 | parecoxib sodium | Lyophilized | Chemical Drugs | Supplementary Application | 2021-03-12 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | In Review | 2021-03-12 | view |
| JYHB2001572 | 注射用帕瑞昔布钠 | parecoxib sodium | Lyophilized | Chemical Drugs | Supplementary Application | 2020-08-26 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2020-10-27 | view |
| JYHB1901462 | 注射用帕瑞昔布钠 | parecoxib sodium | Lyophilized | Chemical Drugs | Supplementary Application | 2019-12-02 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2020-04-22 | view |
| JYHB1901461 | 注射用帕瑞昔布钠 | parecoxib sodium | Lyophilized | Chemical Drugs | Supplementary Application | 2019-12-07 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2020-04-22 | view |
| JYHB1901112 | 注射用帕瑞昔布钠 | parecoxib sodium | Lyophilized | Chemical Drugs | Supplementary Application | 2019-09-16 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2019-09-29 | view |
| JYHB1900965 | 注射用帕瑞昔布钠 | parecoxib sodium | Lyophilized | Chemical Drugs | Supplementary Application | 2019-08-07 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2020-06-02 | view |
| JYHB1900964 | 注射用帕瑞昔布钠 | parecoxib sodium | Lyophilized | Chemical Drugs | Supplementary Application | 2019-08-27 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2020-06-02 | view |
| JYHB1801351 | 注射用帕瑞昔布钠 | parecoxib sodium | Lyophilized | Chemical Drugs | Supplementary Application | 2018-11-21 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2019-01-29 | view |
| JYHB1700871 | 注射用帕瑞昔布钠 | parecoxib sodium | Lyophilized | Chemical Drugs | Supplementary Application | 2017-07-31 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2017-12-19 | view |
| JYHB1500628 | 注射用帕瑞昔布钠 | parecoxib sodium | Lyophilized | Chemical Drugs | Supplementary Application | 2015-05-15 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2018-12-18 | view |
| JYHB1500464 | 注射用帕瑞昔布钠 | parecoxib sodium | Lyophilized | Chemical Drugs | Supplementary Application | 2015-04-17 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2016-05-09 | view |
